Search
for
Sort by
Research 331–360 of 1000+
- Profile analysis of adverse events after boron neutron capture therapy for head and neck cancer: a sub-analysis of the JHN002 study
- Role of 5α-reductase inhibitors in androgen-stimulated skin disorders.
- Cutaneous adverse effects of chemotherapy in cancer patients: A clinico epidemiological study
- Mucocutaneous Side Effects of Antineoplastic Drugs Used in Cancer Therapy in Erbil
- Germline Mutation in ATR in Autosomal- Dominant Oropharyngeal Cancer Syndrome
- Differences in cell subsets between sun-exposed and unexposed skin: preliminary single-cell sequencing and biological analysis from a single case
- Cutaneous Side Effects in Non-Small Cell Lung Cancer Patients Treated with Iressa (ZD1839), an Inhibitor of Epidermal Growth Factor
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil
- Safety of Whole-Body Abrogation of the TRF1 Shelterin Protein in Wild-Type and Cancer-Prone Mouse Models
- The semiotics of breast cancer: Signs, symptoms, and sales
- Signal integrator function of CXXC5 in Cancer
- Target-Adverse Events and Fear of Cancer Progression, Anxiety, and Depression in Patients with Advanced Non-Small Cell Lung Cancer
- The Roles of the Lrig1- and Lgr6-Positive Stem Cells in the Skin and the Functions of the Molecular Markers That Define Them
- Chronic Toxicity Studies of the Potential Cancer Preventive 2-(Difluoromethyl)-<i>dl</i>-ornithine
- Accumulation of I131 by the skin and hair of animals and man
- Microneedles as transdermal drug delivery system for enhancing skin disease treatment
- Fibrotic enzymes modulate wound‐induced skin tumorigenesis
- 642 Uncovering the role of UV exposure history and genetics in determining skin sun damage
- BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i>-Mutant Thyroid Cancer
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Trichomegaly of the Eyelashes After Treatment with Erlotinib in Non-small Cell Lung Cancer
- Perspectives in dermatopathology: telomeres and telomerase in ageing and cancer; with emphasis on cutaneous disease
- A Prospective Observational Study for Assessment of Chemotherapy-Induced Adverse Drug Reactions in Cancer Patients
- Multiscale spatial mapping of cell populations across anatomical sites in healthy human skin and basal cell carcinoma
- Dermoscopy — 4th Conference of the Section of Dermoscopy and Other Skin Imaging Techniques (DiTOS) of the Polish Dermatological Society — Abstracts
- Combinatorial Therapy of Letrozole- and Quercetin-Loaded Spanlastics for Enhanced Cytotoxicity against MCF-7 Breast Cancer Cells
- Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer
- 15809 Spironolactone use does not increase the risk of estrogen-dependent cancer recurrence: A retrospective analysis
- The non-neuronal and nonmuscular effects of botulinum toxin: an opportunity for a deadly molecule to treat disease in the skin and beyond